Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Leukemia (All Stages^), 2014-2018

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by CI*Rank
State
 sort alphabetically by name ascending
Met Healthy People Objective of ***?
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank ascending
Average Annual Count
 sort by count descending
Recent Trend
Recent 5-Year Trend in Incidence Rates
(95% Confidence Interval)
 sort by trend descending
US (SEER+NPCR) 1 *** 14.2 (14.1, 14.2) N/A 51,953 falling falling trend -2.5 (-3.3, -1.6)
District of Columbia 6 *** 9.1 (8.1, 10.2) 51 (49, 51) 59 stable stable trend -0.3 (-2.4, 1.9)
Hawaii 7 *** 10.5 (9.8, 11.2) 50 (46, 51) 180 falling falling trend -3.2 (-5.5, -0.8)
Virginia 6 *** 10.8 (10.5, 11.1) 49 (47, 50) 994 falling falling trend -4.0 (-7.4, -0.5)
Arizona 6 *** 10.8 (10.5, 11.2) 48 (46, 50) 860 falling falling trend -3.9 (-7.0, -0.6)
Alaska 6 *** 11.7 (10.5, 12.9) 47 (30, 50) 81 stable stable trend -1.4 (-3.1, 0.3)
Mississippi 6 *** 12.1 (11.6, 12.7) 46 (36, 47) 406
*
*
Wyoming 6 *** 12.2 (11.0, 13.4) 45 (24, 50) 82 stable stable trend 0.4 (-1.4, 2.3)
California 7 *** 12.3 (12.2, 12.5) 44 (39, 47) 5,073 falling falling trend -3.3 (-4.4, -2.2)
Ohio 6 *** 12.4 (12.1, 12.7) 43 (36, 47) 1,712 stable stable trend 0.0 (-0.4, 0.3)
Vermont 6 *** 12.4 (11.3, 13.6) 42 (22, 49) 98 stable stable trend -1.3 (-2.7, 0.0)
Maryland 6 *** 12.5 (12.1, 12.9) 41 (34, 47) 837 stable stable trend -2.9 (-6.2, 0.5)
Massachusetts 7 *** 12.6 (12.3, 13.0) 40 (34, 46) 1,013 stable stable trend -0.8 (-1.7, 0.0)
Delaware 6 *** 12.7 (11.8, 13.7) 39 (22, 47) 150 falling falling trend -6.3 (-12.1, -0.1)
Alabama 6 *** 12.8 (12.3, 13.2) 38 (31, 46) 726 rising rising trend 1.1 (0.5, 1.7)
Nevada 6 *** 12.8 (12.2, 13.5) 37 (27, 47) 320
*
*
South Carolina 6 *** 12.9 (12.5, 13.3) 36 (30, 44) 759 falling falling trend -3.1 (-3.9, -2.2)
Colorado 6 *** 13.0 (12.6, 13.5) 35 (29, 43) 751 falling falling trend -2.9 (-4.1, -1.7)
Oregon 6 *** 13.0 (12.6, 13.5) 34 (28, 44) 629 rising rising trend 0.9 (0.4, 1.5)
Tennessee 6 *** 13.4 (13.0, 13.8) 33 (26, 38) 1,025 stable stable trend -3.0 (-5.9, 0.1)
Indiana 6 *** 13.5 (13.1, 13.9) 32 (24, 37) 1,005 stable stable trend -5.0 (-10.9, 1.2)
New Mexico 7 *** 13.5 (12.8, 14.2) 31 (19, 42) 325 stable stable trend 0.2 (-0.2, 0.5)
Illinois 6 *** 13.5 (13.2, 13.8) 30 (26, 36) 1,940 falling falling trend -0.4 (-0.7, -0.1)
New Hampshire 6 *** 13.6 (12.8, 14.5) 29 (14, 43) 227 stable stable trend -5.1 (-10.1, 0.2)
Missouri 6 *** 13.9 (13.5, 14.3) 28 (17, 33) 1,001 stable stable trend 0.3 (-0.2, 0.8)
Louisiana 7 *** 14.0 (13.5, 14.4) 27 (16, 34) 718 stable stable trend -3.7 (-8.2, 1.0)
Michigan 5 *** 14.0 (13.7, 14.3) 26 (19, 31) 1,669 stable stable trend -0.2 (-0.7, 0.3)
Connecticut 7 *** 14.0 (13.5, 14.6) 25 (15, 33) 616 stable stable trend -1.8 (-4.9, 1.4)
Oklahoma 6 *** 14.1 (13.6, 14.6) 24 (14, 33) 619 stable stable trend -1.0 (-2.1, 0.2)
Texas 6 *** 14.1 (13.9, 14.3) 23 (18, 29) 3,819 stable stable trend -0.4 (-0.7, 0.0)
Utah 7 *** 14.4 (13.8, 15.1) 22 (11, 32) 389 rising rising trend 0.9 (0.6, 1.2)
Nebraska 6 *** 14.4 (13.7, 15.2) 21 (10, 33) 312 stable stable trend -0.4 (-1.0, 0.2)
Washington 5 *** 14.5 (14.1, 14.9) 20 (13, 27) 1,177 falling falling trend -2.0 (-3.4, -0.7)
North Carolina 6 *** 14.5 (14.2, 14.8) 19 (13, 26) 1,684 stable stable trend -2.6 (-6.6, 1.7)
Georgia 7 *** 14.6 (14.3, 14.9) 18 (12, 25) 1,543 stable stable trend -2.7 (-5.5, 0.2)
Arkansas 6 *** 14.7 (14.1, 15.3) 17 (10, 28) 519 rising rising trend 1.8 (0.9, 2.8)
Rhode Island 6 *** 14.7 (13.7, 15.7) 16 (6, 33) 187 stable stable trend 0.5 (-0.2, 1.2)
Maine 6 *** 14.8 (14.0, 15.7) 15 (7, 31) 267 stable stable trend -0.3 (-1.2, 0.6)
Kansas 6 *** 14.9 (14.3, 15.6) 14 (9, 26) 489 falling falling trend -5.4 (-9.3, -1.4)
Montana 6 *** 15.0 (14.1, 16.0) 13 (4, 30) 199 stable stable trend 0.1 (-0.7, 0.8)
Pennsylvania 6 *** 15.1 (14.8, 15.4) 12 (10, 18) 2,430 falling falling trend -1.1 (-1.8, -0.3)
West Virginia 6 *** 15.6 (14.9, 16.4) 11 (2, 20) 370 rising rising trend 1.0 (0.3, 1.6)
North Dakota 6 *** 15.8 (14.6, 17.1) 10 (2, 26) 132 stable stable trend -0.7 (-1.8, 0.5)
New Jersey 7 *** 15.9 (15.5, 16.2) 9 (5, 13) 1,651 rising rising trend 0.9 (0.5, 1.2)
Kentucky 7 *** 15.9 (15.4, 16.4) 8 (3, 13) 816 stable stable trend -1.6 (-3.3, 0.1)
New York 7 *** 16.3 (16.0, 16.5) 7 (3, 10) 3,761 stable stable trend -3.4 (-7.9, 1.4)
Idaho 7 *** 16.4 (15.5, 17.2) 6 (2, 13) 303 rising rising trend 0.8 (0.1, 1.4)
South Dakota 6 *** 16.4 (15.3, 17.6) 5 (1, 17) 165 stable stable trend 0.9 (-0.2, 2.0)
Wisconsin 6 *** 16.6 (16.2, 17.1) 4 (2, 9) 1,151 falling falling trend -2.9 (-4.3, -1.4)
Iowa 7 *** 16.7 (16.1, 17.3) 3 (2, 9) 633 rising rising trend 0.3 (0.1, 0.6)
Minnesota 6 *** 16.7 (16.3, 17.2) 2 (2, 8) 1,060 rising rising trend 0.7 (0.2, 1.2)
Florida 6 *** 18.2 (18.0, 18.5) 1 (1, 2) 5,025 falling falling trend -6.1 (-9.0, -3.1)
Puerto Rico 6 *** 10.0 (9.6, 10.5) N/A 420 stable stable trend -3.4 (-13.4, 7.8)
Notes:
Created by statecancerprofiles.cancer.gov on 12/02/2021 1:13 am.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The 1969-2018 US Population Data File is used for SEER and NPCR incidence rates.
‡ Incidence data come from different sources. Due to different years of data availability, most of the trends are AAPCs based on APCs but some are APCs calculated in SEER*Stat. Please refer to the source for each area for additional information.

Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
*** No Healthy People 2020 Objective for this cancer.
Healthy People 2020 Objectives provided by the Centers for Disease Control and Prevention.

* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2018) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2020 submission.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2018) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2020 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database (2001-2018) - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2020 submission).
7 Source: SEER November 2020 submission.
8 Source: Incidence data provided by the SEER Program. AAPCs are calculated by the Joinpoint Regression Program and are based on APCs. Data are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84,85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Population counts for denominators are based on Census populations as modifed by NCI. The 1969-2018 US Population Data File is used with SEER November 2020 data.

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data for United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top